|
CN101342151A
|
|
Isosorbide mononitrate osmotic pump type controlled release formulation and preparation method thereof
|
|
CN101481323A
|
|
Benzo cyclohepten derivate, and preparation and medical use thereof
|
|
CN101468985A
|
|
5-(3-aromatic heterocyclic substituted phenyl) tetrazole compounds and anti-HIV/AIDS use thereof
|
|
CN101440113A
|
|
Colchicine derivative-bile acid coupling compounds and medical use thereof
|
|
CN101439187A
|
|
Novel coupling compound of bile acid and anti-hepatitis virus medicament and medical use thereof
|
|
CN101407522A
|
|
Preparation of amyrolin and derivatives thereof
|
|
CN101407467A
|
|
N-substituted arene aniline / polysubstituted diaryl ether compound, preparation and anti-tumor use thereof
|
|
CN101353320A
|
|
Matrix metalloprotease inhibitors, medicinal composition containing the same, preparation and use thereof
|
|
CN101293899A
|
|
Acyclic nucleoside phosphonate derivative and medicine use thereof
|
|
CN101062906A
|
|
Agmatine sulfate hydrate and usage for drug rehabilitation, antiphlogistic, hypoglycemic and agmatine metabolism abnormality induced disease
|
|
CN101012304A
|
|
Use of nucleic acid base compound in preparing medicinal biodegradation material and method of preparing medicinal biodegradation material
|
|
CN101012305A
|
|
Use of amino acid in preparing medicinal biodegradation material and method of preparing medicinal biodegradation material
|
|
CN101209273A
|
|
Preparation of inula japonica total polysaccharide and its application in defaecation and expelling toxin
|
|
CN101209993A
|
|
Medical use for levorotatory phencynonate as nerve protecting agent
|
|
CN101012196A
|
|
Fragrant geldanamycin derivative and its preparing method and use
|
|
CN101190904A
|
|
Fatty acid synthetic enzyme inhibitor and medical preparation use thereof
|
|
CN101190894A
|
|
Fatty acid synthetic enzyme inhibitor and medical preparation use thereof
|
|
CN101172978A
|
|
Six-member heterocyclic compounds, prepare method and medical uses of the same
|
|
CN101121751A
|
|
PTD-tyrosine hydroxylase catalysis region fusion protein and application thereof
|
|
CN1965809A
|
|
Sustained-release microsphere of LHRH antagonist for injection and preparation process thereof
|
